Pharma Beart SRL
2.7 FTEThe score of Pharma Beart shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +18 % Headcount (avg FTE) +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Beart's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 227,087 € | ||||
| Equity | 985,531 € | ||||
| Cash | 427,758 € | ||||
| EBITDA | 375,031 € | ||||
| Total assets | €1.22m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 May 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 28 May 2024
- Year ended 31 Dec 2022filed on 01 Jun 2023
- Year ended 31 Dec 2021filed on 31 May 2022
Pharma Beart's financial analysis
- Solvency80.6%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Beart
Pharma Beart's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0892.584.397
- VAT number
- BE0892584397
- Peppol
- Registered · 0208:0892584397 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Oct 2007
- Registered office
- 7170 Manage
- Size
- Micro · 2.7 FTE
- Latest accounts
- 2025 · filed on 29 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Beart (SRL) has been based in Manage since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 227,087 € and equity of 985,531 €; its revenue is not published. With 2.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 80.6%, above the median of its sector (41.5%).
Companies similar to Pharma Beart
Companies in the same business, of comparable size and area, outside its group.
- Langenaken Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet €1.22m
- Apoteek Van Bulck Retail sale of pharmaceutical products Beringen · balance sheet €1.22m
- Aclot Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.22m
- Apotheek Reymen Retail sale of pharmaceutical products Laakdal · balance sheet €1.22m
- PHARMACIE Charleroi Nord Retail sale of pharmaceutical products Charleroi · balance sheet €1.22m
- Vandenabeele-Hungenaert Retail sale of pharmaceutical products Damme · balance sheet €1.23m
- Cynara Retail sale of pharmaceutical products Brussels · balance sheet €1.22m
- Niemegeers-Engels BV Retail sale of pharmaceutical products Asse · balance sheet €1.23m
Frequently asked questions about Pharma Beart
What is the revenue of Pharma Beart?
Pharma Beart files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Beart?
In Belgium, the VAT number is the company number prefixed with BE: BE0892584397 for Pharma Beart, if the company is VAT-registered. Its company number (CBE) is 0892.584.397.
Where is the registered office of Pharma Beart?
According to the CBE register, the registered office of Pharma Beart is in 7170 Manage.
What is the equity of Pharma Beart?
At the close of the 2025 financial year, the equity of Pharma Beart amounts to 985,531 €, a solvency of 80.6% of total assets.
How many people work at Pharma Beart?
2.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Beart?
The register lists 1 active mandates at Pharma Beart. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Beart
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →